C
hronic kidney disease (CKD) has received increased attention since the introduction of the definition and classification system from the National Kidney Foundation (NKF) CKD guidelines in February 2002. 1 Several investigators estimated the size of the noninstitutionalized CKD population to be between 11.5% and 14%, judging from estimated glomerular filtration rates (eGFRs) and evidence of microalbuminuria from the National Health and Nutrition Examination Survey in the United States between 1988 and 1994 and 1999 and 2004. [2] [3] [4] Approximately 20 million adults in the United States are estimated to have evidence of increased albumin-creatinine ratio (ACR; Ն30 mg/g) and decreased eGFR (Ͻ60 mL/min/1.73 m 2 [Ͻ1.00 mL/s/1.73 m 2 ]); however, only about 100,000 reach end-stage renal disease each year. 2, 5, 6 All-cause and cardiovascular death appear to be more likely outcomes for patients with CKD than reaching endstage renal disease. 7 CKD detection efforts have been developed throughout the world, but few are as large as the NKF Kidney Early Evaluation Program (KEEP), [8] [9] [10] [11] which includes follow-up to determine whether participants seek medical care after the initial screening event. KEEP targets adults with self-reported diabetes, hypertension, or a family history of these diseases or kidney disease. Upon completion of the screening program, participants receive information about laboratory results and measurements of blood pressure, body mass index, blood glucose, hemoglobin, serum creatinine, eGFR, and evidence of proteinuria. However, little information is available regarding KEEP participants' follow-up care relative to the frequency of and reasons for physician visits. We analyzed KEEP participants from 2000 to 2006, evaluating the likelihood of following up with physicians in the 3 months after participating in the screening program to determine factors that influence the decision to visit a physician, reasons for the visit, and care interventions.
METHODS

Subjects
As described elsewhere in this supplement, 12 eligible KEEP participants were 18 years or older with self-reported diabetes or hypertension or a first-degree relative with diabetes, hypertension, or kidney disease. We included only eligible KEEP participants from August 2000 through December 31, 2006, from 47 NKF affiliates and 1,608 screening programs in 49 states and the District of Columbia. The KEEP cohort in this study, excluding individuals with missing data values, consists of 73,460 eligible KEEP participants. Participants receive health screening reports within a month of completing the screening program. Within the next month, a follow-up survey form is sent to any participant who was identified with at least 1 abnormal test result or preexisting comorbid condition. The primary goal of the follow-up survey form is to encourage participants to seek medical consultation and care regarding the screening test results.
Definitions
Diabetes was defined as self-reported history of diabetes or retinopathy, receiving oral medication or insulin for diabetes, or increased blood glucose, defined as glucose level of 126 mg/dL or greater (Ն7.0 mmol/L) if fasting or 200 mg/dL or greater (Ն11.1 mmol/L) if nonfasting. Hypertension was defined as self-reported history of high blood pressure, receiving medication for high blood pressure, or increased blood pressure, 13 defined as systolic blood pressure of 130 mm Hg or greater or diastolic blood pressure of 80 mm Hg or greater for persons with a history of diabetes or CKD, otherwise systolic blood pressure of 140 mm Hg or greater or diastolic blood pressure of 90 mm Hg or greater. Cardiovascular disease was defined as self-reported heart attack, heart bypass surgery, heart angioplasty, stroke, heart failure, abnormal heart rhythm, or peripheral vascular disease (applicable only to the pre-May 2005 form). Anemia was defined as per the World Health Organization, as hemoglobin level less than 13 g/dL (Ͻ130 g/L) for men and less than 12 g/dL (Ͻ120 g/L) for women. eGFR was calculated using the isotope dilution mass spectometry-traceable 4-vari- 
Analysis
Follow-up response rate was calculated by dividing the numerator (number of participants who returned follow-up forms and answered the question about seeing a physician about the screening result) by the denominator (number of participants who received follow-up forms). The percentage of participants who returned follow-up forms and reported seeing a physician was compared by using individual health condition and CKD progression indicators. The 2 test was used to determine P values for these comparisons. Multivariable logistic regressions were used for calculating odds ratios of returning follow-up forms and reporting physician visits about the screening results, respectively. Predictor variables included age, sex, race, region, education, smoking status, health insurance access, diabetes, hypertension, selfreported cardiovascular disease, obesity, anemia, and levels of eGFR. P less than 0.05 is considered statistically significant.
RESULTS
Of 73,460 eligible KEEP participants, 72,395 received follow-up forms. Of these, 20,541 participants returned the follow-up forms and reported seeing a physician about the screening results, a response rate of 28.4% ( ‡Body mass index of 30 kg/m 2 or greater. §As defined by the World Health Organization, a hemoglobin level less than 13 g/dL (Ͻ130 g/L) for men and less than 12 g/dL (Ͻ120 g/L) for women.
Of the 20,541 participants who returned follow-up forms, 14,590 (71%) reported seeing a physician about their screening results, 5,951 reported not seeing a physician, and 661 did not answer the question. Greater percentages of participants with diabetes, hypertension, cardiovascular disease, or anemia or with evidence of CKD visited physicians about their screening results (Table 3) . Using the multivariable logistic model, older age, female sex, African American race, living in a region other than the West, currently not a smoker, and obesity are signifi- ‡As defined by the World Health Organization, a hemoglobin level less than 13 g/dL (Ͻ130 g/L) for men and less than 12 g/dL (Ͻ120 g/L) for women.
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cant predictors of visiting a physician regarding screening results ( Of the 3,340 participants who learned they had hypertension, 51.3% were monitoring blood pressure, 16.6% adjusted their diets, and 49.9% received prescription medicine (Table 5) . Of the 1,599 participants who learned they had diabetes, 50.6% were monitoring blood glucose levels, 34.3% adjusted their diets, 40.7% received prescription medicine, and 9.9% were prescribed insulin. Of the 528 persons who learned they had anemia, 32.8% were prescribed over-the-counter medication, 19.7% received prescription medicine, and 9.3% were prescribed injections. ‡Body mass index of 30 kg/m 2 or greater. §As defined by the World Health Organization, a hemoglobin level less than 13 g/dL (Ͻ130 g/L) for men and less than 12 g/dL (Ͻ120 g/L) for women.
DISCUSSION
This suggests that the health-screening program supported by a targeted educational plan with increasing vigilance in follow-up of participants with evidence of more advanced CKD can lead to increased participant access to the medical system.
Of KEEP participants who returned their follow-up forms, 71% indicated that they saw their physicians after the KEEP event. When categorized by evidence of CKD, 24% more participants with CKD reported seeing a physician than participants without evidence of CKD. Participants with decreased kidney function and increased urine albumin levels were more likely to report visiting physicians after the KEEP event.
Predictors of increased likelihood of reporting a physician visit were age, sex, race, geographic region, insurance status, and decreased kidney function indicated by using eGFR. For participants with medical insurance, the chance of reporting physician follow-up increased by 90%, confirming the importance of access to the health care system. For participants with an eGFR less than 30 mL/min/1.73 m 2 (Ͻ0.50 mL/s/1.73 m 2 ), the likelihood was 3.7 times greater than for those with an eGFR greater than 60 mL/min/1.73 m 2 (Ͻ1.00 mL/s/1.73 m 2 ), suggesting that targeted groups were accessing the health care system.
Participants' indicated reasons for physician visits provide insight into how they leverage the information obtained from the detection program. Of those with increased blood pressure at the screening, two thirds indicated that they saw their physicians for that finding. Of those with evidence of kidney damage, 50% saw their physicians for that finding. Although follow-up data are limited to 28% of people who participated in the program, they provide important observations regarding activities in the immediate 3-month follow-up period. Because the main purpose of KEEP is to engage the population at risk of kidney disease to participate in the program and seek further medical care, the program appears to be meeting its objective. Receiving health information at the end of the program and consulting with a health care professional to review health status and risk factors appears to motivate participants to engage the health care system. Educational materials that participants receive include information about kidney disease, risk factors, and lifestyle changes, such as weight loss, blood pressure control, and, for those with diabetes, blood glucose control. Kidney disease treatments as defined in clinical practice guidelines also are reviewed, and participants are encouraged to discuss them with their physicians. The targeted nature of follow-up activities for participants with evidence of an eGFR less than 60 mL/min/1.73 m 2 (Ͻ1.00 mL/s/1.73 m 2 ) likely explains the increased odds of participants with the lowest eGFRs seeing their physician. The educational effort also helps inform at-risk participants with hypertension and diabetes.
Whether the health-screening program and subsequent follow-up physician visits changed outcomes for these participants compared with those who did not follow up with physician visits is unclear from the data. Long-term strategies to follow up individuals with evidence of mild to moderate CKD should be designed and implemented.
In this evaluation of the KEEP cohort regarding participants who provide follow-up information, the response rate was close to 30% and considerably greater in the targeted low-eGFR population. The short-term follow-up should be expanded to determine whether longer term health status and medical care are changed for program participants and whether providers change the care of similar patients in their practices.
Generalization of our results is limited by the low response rate in returning follow-up forms, Follow-up in KEEP S75 with significant differences in age, sex, race, smoking history, education, and some health conditions between participants who returned and did not return follow-up forms. Results based on the group that returned follow-up forms thus might be biased. Results for medical interventions (Table 5 ) also are limited. Because we did not collect medical intervention data at baseline, we cannot conclude any influence on changes in medical intervention by the findings of KEEP. The KEEP detection program appears to successfully identify individuals at high risk of CKD and motivate participants with evidence of kidney damage to seek physician care in the 3 months after the screening event. Additional longterm assessment of participants regarding their subsequent care and outcomes is needed.
